ZJYL Jin Medical International Ltd. Annual reports only
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1837821 · Fiscal year ends 09/30
Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-12.0%
TTM net income YoY-67.6%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR2.5%
Net income 3-yr CAGR-23.9%
Margins
Gross margin29.2%
Operating margin2.9%
Net margin5.8%
FCF margin-18.0%
EBITDA margin4.1%
Returns
ROE4.1%
ROA2.4%
ROIC (approx.)2.5%
Asset turnover0.42x
Leverage & solvency
Liabilities / assets44.6%
Debt / equity0.00x
Current ratio1.86x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.44x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue32.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 | FY20222022-09-30 | FY20212021-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $20.69M | $23.50M | $19.82M | $19.19M | $20.76M |
| Cost of revenue | $14.64M | $14.00M | $13.04M | $12.99M | $14.40M |
| Gross profit | $6.04M | $9.50M | $6.78M | $6.20M | $6.36M |
| R&D expense | $1.56M | $1.50M | $1.54M | $1.89M | $1.57M |
| SG&A expense | $2.53M | $3.26M | $1.92M | $1.77M | $1.67M |
| Operating income | $608,182 | $3.64M | $2.87M | $2.13M | $2.63M |
| Pretax income | $1.60M | $4.18M | $3.22M | $2.74M | $2.88M |
| Income tax | $214,572 | $763,879 | $343,707 | $36,111 | $248,641 |
| Net income | $1.19M | $3.68M | $2.88M | $2.71M | $2.63M |
| EBITDA | $851,585 | $3.88M | $3.09M | $2.49M | $2.98M |
| EPS (basic) | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| EPS (diluted) | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| Weighted avg. shares (diluted) | 156.55M | 156.47M | 145.14M | 135.00M | 135.00M |
| Banking | |||||
| Net interest income | — | — | $182,682 | $181,605 | -$9,492 |
| Balance sheet | |||||
| Cash & equivalents | $7.46M | $8.14M | $6.93M | $4.79M | $3.67M |
| Short-term investments | $22.17M | $18.62M | $9.77M | $2.28M | — |
| Receivables | $5.81M | $5.91M | $3.28M | $3.83M | — |
| Inventory | $4.92M | $5.17M | $5.05M | $6.72M | — |
| Current assets | $44.14M | $42.82M | $31.12M | $18.90M | — |
| PP&E, net | $7.90M | $1.46M | $1.48M | $1.63M | — |
| Intangibles | $1.10M | $1.15M | $154,364 | — | — |
| Total assets | $53.37M | $45.80M | $32.90M | $20.94M | — |
| Current liabilities | $23.80M | $17.15M | $8.92M | $5.70M | — |
| Short-term debt | $18.84M | $11.32M | $4.11M | — | — |
| Total liabilities | $23.80M | $17.25M | $8.92M | $5.70M | — |
| Shareholders' equity | $29.64M | $28.82M | $23.98M | $15.24M | $14.03M |
| Shares outstanding | 156.55M | 155.95M | 155.95M | 135.00M | — |
| Cash flow statement | |||||
| Operating cash flow | $2.90M | -$1.21M | $3.11M | $1.58M | $5.84M |
| Capital expenditure | $6.63M | $144,949 | $113,937 | $40,166 | $42,881 |
| Free cash flow | -$3.73M | -$1.35M | $2.99M | $1.54M | $5.80M |
| Investing cash flow | -$10.79M | -$9.51M | -$7.73M | -$120,904 | -$1.07M |
| Financing cash flow | $7.35M | $11.65M | $6.91M | $121,855 | -$2.87M |
| Depreciation & amortization | $243,403 | $237,823 | $225,902 | $362,597 | $346,608 |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.